Abstract:Patient: Female, 45-year-old
Final Diagnosis: Leiomyoma with massive cystic hydropic degeneration
Symptoms: Abdominal distention and pain
Medication:—
Clinical Procedure: —
Specialty: Surgery
Objective:
Rare disease
Background:
Ovarian leiomyomas are rare, benign, smooth muscle, solid tumors that occur in women aged 20 to 65 years. Because their histology is benign, the prognosis for patients is goo… Show more
“…The coexistence of ovarian leiomyomas with uterine leiomyomas has been reported ( 6 , 7 ). In this group of 7 OL patients, 3 had uterine leiomyomas and 2 had endometrial polyps, which are in good accordance with reports in the literature.…”
ObjectivesOvarian leiomyomas (OLs) are rare and account for only 0.5 to 1% of benign ovarian tumors. This study investigated the ultrasonographic manifestations of OL and the potential reasons for misdiagnosis.MethodsBetween July 2018 and July 2023, 7 patients diagnosed with OL by surgical pathology and immunohistochemistry were enrolled in this retrospective analysis. Ultrasound (US) examinations were performed before surgery. Clinical characteristics, pathological findings, ultrasonographic manifestations, and treatment were reviewed.ResultsThe mean age of the 7 patients was 39.0 ± 11.57 years, with a disease course of 0.1 to 24 months. All ovarian leiomyomas were unilateral. Four cases occurred in the right ovary, and three cases occurred in the left ovary. All lesions presented as hypoechogenic, well-circumscribed, round or oval in shape, and regular in morphology. No significant blood flow signal was detected peripheral to or inside the mass in 3 cases (42.8%), and a minimal flow signal was detected peripheral to or inside the mass in 4 cases (58.2%). A total of 7 ultrasonographic images of OL were misdiagnosed: 1 patient was misdiagnosed with subserosal uterine leiomyoma, and 6 patients were misdiagnosed with a tumor in the ovarian thecoma–fibroma group.ConclusionThe imaging manifestation of OL lacks specificity; thus, preoperatively distinguishing OL from other ovarian tumors and subserosal uterine leiomyomas is difficult. Immunohistochemistry may be helpful for the definitive diagnosis of OL. The possibility of ovarian leiomyoma should be considered in patients with uterine leiomyomas coexisting with an adnexal ovarian solid mass.
“…The coexistence of ovarian leiomyomas with uterine leiomyomas has been reported ( 6 , 7 ). In this group of 7 OL patients, 3 had uterine leiomyomas and 2 had endometrial polyps, which are in good accordance with reports in the literature.…”
ObjectivesOvarian leiomyomas (OLs) are rare and account for only 0.5 to 1% of benign ovarian tumors. This study investigated the ultrasonographic manifestations of OL and the potential reasons for misdiagnosis.MethodsBetween July 2018 and July 2023, 7 patients diagnosed with OL by surgical pathology and immunohistochemistry were enrolled in this retrospective analysis. Ultrasound (US) examinations were performed before surgery. Clinical characteristics, pathological findings, ultrasonographic manifestations, and treatment were reviewed.ResultsThe mean age of the 7 patients was 39.0 ± 11.57 years, with a disease course of 0.1 to 24 months. All ovarian leiomyomas were unilateral. Four cases occurred in the right ovary, and three cases occurred in the left ovary. All lesions presented as hypoechogenic, well-circumscribed, round or oval in shape, and regular in morphology. No significant blood flow signal was detected peripheral to or inside the mass in 3 cases (42.8%), and a minimal flow signal was detected peripheral to or inside the mass in 4 cases (58.2%). A total of 7 ultrasonographic images of OL were misdiagnosed: 1 patient was misdiagnosed with subserosal uterine leiomyoma, and 6 patients were misdiagnosed with a tumor in the ovarian thecoma–fibroma group.ConclusionThe imaging manifestation of OL lacks specificity; thus, preoperatively distinguishing OL from other ovarian tumors and subserosal uterine leiomyomas is difficult. Immunohistochemistry may be helpful for the definitive diagnosis of OL. The possibility of ovarian leiomyoma should be considered in patients with uterine leiomyomas coexisting with an adnexal ovarian solid mass.
“…Ovarian leiomyoma has a rare incidence, which is thought to account for 0.5%–1% of all benign ovarian tumors 1,2 . So far, fewer than 200 cases have been reported since it was first described in 1862 3 .…”
Section: Introductionmentioning
confidence: 99%
“…Ovarian leiomyoma has a rare incidence, which is thought to account for 0.5%–1% of all benign ovarian tumors. 1 , 2 So far, fewer than 200 cases have been reported since it was first described in 1862. 3 There are no specific clinical manifestations, tumor markers, or imaging features of ovarian leiomyoma.…”
Key Clinical MessageOvarian leiomyoma and abdominal wall leiomyoma are both rare clinical entities. Here, we report the rare case with ovarian leiomyoma accompanied by a neglected abdominal wall leiomyoma to raise the awareness of clinicians of ovarian leiomyoma and multiple occurrences of benign leiomyoma for appropriate diagnosis.
“…Обычно ЛМЯ -это односторонняя опухоль небольшого размера, которая обнаруживается у пациенток с ЛММ [6,7]. В то же время описаны случаи двухстороннего поражения яичников этой опухолью.…”
unclassified
“…ЛМЯ встречаются у женщин в возрасте от 20 до 65 лет [1,5]. В доступной литературе были представлены отчёты о клинических случаях ЛМЯ как у возрастных женщин в период постменопаузы [5,6], так и у пациенток, находящихся в молодом и даже подростковом возрасте. При этом обзор литературы показывает, что в отличие от пожилых пациенток у пациенток подросткового возраста и молодых женщин одновременно с ЛМЯ обычно не отмечается сопутствующая ЛММ.…”
A small, unilateral tumor. Most ovarian leiomyomas (OLM) are benign, but can range from benign to borderline with malignant degeneration. In many patients, OLM are asymptomatic and are detected accidentally during surgery. In rare cases, OLM can be accompanied by severe symptoms as their size increases. This situation requires differentiation these formations from malignant ovarian tumors, which is more often observed during the perimenopausal and menopausal periods. Being discussed that the source of OLM is smooth muscle blood vessel cells, so more undiagnosed small asymptomatic OLMs can be expected. This article presents a clinical case of OLM in a 39-year-old woman operated for uterine myoma. In the case we presented the coexistence of uterine fibroids and ovarian leiomyoma, which subsequently received diagnostic confirmation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.